HealthFinancing
Ultragenyx Pharmaceutical agrees to US$203M priority review voucher sale
Cash is payable at closing, subject to antitrust conditions; two announced voucher agreements total US$413 million.
FDA expands ImmunityBio's Anktiva label to papillary-only bladder cancer
The approval adds adults with high-grade, BCG-unresponsive disease ahead of the Jan. 6, 2027 review target.
MiningCopper
P2 Gold identifies new gold-copper unit within Sullivan PEA pit shell
A 70.10-metre intercept could reduce waste mining at Gabbs, where a feasibility study is targeted for the first quarter of 2027.
Analysis
Rio Tinto keeps 2026 guidance as Oyu Tolgoi copper output rises 27%
Consolidated copper output was flat at 205,000 tonnes in the third quarter, while the Mongolian operation ran at an annualised 450,000 tonnes.
Health
AMS: PHARMPharming Group reports 26.4% spleen reduction in Phase 2 leniolisib trial
The 13-person study had no control group and a safety primary endpoint, with a separate CVID readout expected in November.
MiningGold
Thor Explorations cuts annual gold guidance to 70K to 72K oz
The Nigerian mine poured 15,515 ounces in the third quarter, while Thor maintained its C$0.0125 quarterly dividend.
HealthStock News
Mayne Pharma wins dismissal of Cosette appeal over abandoned takeover
The court awarded appeal costs; the A$7.40-a-share deal was terminated in December 2025, and Mayne is pursuing damages.
Mining
ASX: GRRThe sub-level cave is expected to sustain pellet supply through 2035, funded from existing cash reserves and open-pit cash flows.
Mining
ASX: RRLThe miner will keep pursuing an alternative waste-storage design while it anticipates a ministerial redetermination.
Analysis
Olympus Corporation receives FDA warning over six facilities
The Oct. 7 letter addresses quality-system responses, while Olympus says it brings no new production or distribution restrictions.
Latest
Digi Power X receives US$200M debt commitment for Alabama AI campus
The proposed project debt awaits lender diligence and final documents as Phase 1 completion remains targeted for December 2026.
Tilray Brands gains approval for in‑house cannabis testing in Portugal
INFARMED authorized microbiological and chemical/physical tests at Cantanhede, where Tilray expects faster batch releases and lower costs.
BP forecasts net debt of US$13.5B to US$14.5B as refining margins rise
BP flags US$3B to US$4.5B in total post-tax impairments, primarily attributable to transition businesses, ahead of Oct. 30 results.
Many Peaks Minerals Limited reports 188.9m at 3.58 g/t ahead of Ferké resource update
The estimated true width is 95.3 metres, and the new assays mark the planned data cut-off for an estimate expected in the December quarter.
Maronan Metals Limited secures A$20M placement commitments
Kinterra would lift its interest to 22.99 per cent, with both share tranches conditional on approval at the Nov. 4 annual meeting.
Bitdeer Technologies Group signs eight-year deal for 60 MW AI facility
A103 lifts secured AI cloud capacity to 333.5 MW, but has no customer offtake and is expected to be energized in early 2028.
Mentioned this week
Mining & Critical Minerals
Gold, silver, uranium, lithium, copper and rare earths: the producers, the developers and the projects behind them.
View all
MiningGold
Xtra-Gold Resources lifts Kibi indicated gold resource 33% to 1.4Moz
The estimate includes 156,100 indicated ounces in a buffer zone where formal approval to extend the mining lease remains pending.
More in Mining
Health & Science
Medical and pharmaceutical developments, psychedelics, and the research and safety questions around them.
View all
Health
NASDAQ: LQDAPAH sales continue, PH-ILD promotion ends and cash payments run into April 2027; Liquidia expects to fund them without new financing.
Markets & Technology
Technology, computing, crypto and cannabis, and the listed companies moving in them.
View all
TechnologyBitcoin
Strive proposes 15% preferred offering with US$75M annual dividend cost
Five million proposed shares carry a US$100 stated amount, while the preliminary prospectus leaves the sale price and fees blank.
Cannabis
TSE: WEEDCanopy Growth gains EU GMP certification for Smiths Falls softgels
Germany's Tübingen authority certified softgel manufacturing and primary packaging of softgels, oral liquids and dried cannabis flower.
Energy
Uranium, lithium, oil and gas, hydrogen and the grid: the fuels and the companies behind them.
View all
Energy
ASX: ARUVolumes are 70 per cent above the May term sheet and will ramp up as Nolans reaches nameplate production.
Energy
LON: SHELEquinor keeps 70 per cent and expects first oil in 2031; its project page estimates C$14 billion in initial investment.
Energy
NYSE: KMIFERC set an Oct. 22 intervention deadline as NGPL seeks 321,200 dekatherms a day of new capacity for power generation.
Cannabis & Psychedelics
Licensed producers, retail, policy, and the psychedelics companies moving through the clinic.
View all
Cannabis
NASDAQ: SHFSThe Sept. 30 balance is up 7.4 per cent from a year earlier; the client deposits are held at Safe Harbor's partner financial institutions.
Cannabis
NYSE: TRLVThe linked customer page carries Oct. 9 closing notices for 13 Florida stores and does not give individual reopening dates.
Cannabis
TSE: CURAThe Oct. 9 joint filing asks the D.C. Circuit to adopt Feb. 19, 2027, as the final briefing date for three consolidated petitions for review.
Cannabis
CNSX: VREOThe Oct. 9 filing follows a July deal to issue 0.015383618 Vireo share per eligible Planet 13 share, subject to shareholder and regulatory approvals.